SCHEMBL7525540

SCHEMBL7525540

Cn1cc(C2=C(c3cn(C)c4cc(N5CCCC5)ccc34)C(=O)NC2=O)c2ccc(C#N)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 2/20 0.49
GSK3B P49841 3/20 0.48
CDK4 P11802 2/20 0.46
CCND1 P24385 2/20 0.46
CDK2 P24941 2/20 0.46
CCNE2 O96020 1/20 0.46
CCNE1 P24864 1/20 0.46
BRD4 O60885 1/20 0.46
CREBBP Q92793 1/20 0.46
JAK3 P52333 1/20 0.43
GSK3A P49840 2/20 0.43
MEN1 O00255 1/20 0.43
RGS12 O14924 1/20 0.43
GMNN O75496 1/20 0.43
USP2 O75604 1/20 0.43
CCNB2 O95067 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CDK1 P06493 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7526149 0.91 GSK3B (0.53) ALKGSK3BCDK4CCND1CDK2
SCHEMBL7990615 0.87 BRD4 (0.43) ALKGSK3BBRD4CREBBPMEN1
SCHEMBL7976776 0.84 CDK4 (0.67) GSK3BCDK4CCND1CDK2CCNE2
SCHEMBL7524580 0.84 GSK3B (0.58) GSK3BCDK4CCND1CDK2CCNE2
SCHEMBL7529269 0.84 GSK3B (0.54) GSK3BCDK4CCND1CDK2CCNE2
SCHEMBL7987101 0.84 CDK4 (0.66) GSK3BCDK4CCND1CDK2CCNE2
SCHEMBL7497372 0.82 GSK3B (0.58) GSK3BCDK4CCND1CDK2CCNE2
SCHEMBL6952413 0.82 CCNE2 (0.71) GSK3BCDK4CCND1CDK2CCNE2
SCHEMBL7990678 0.82 GSK3B (0.59) GSK3BCDK4CCND1CDK2CCNE2
SCHEMBL7502705 0.81 GSK3B (0.54) GSK3BCDK4CCND1CDK2CCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242409-A2 SUBSTITUTED BISINDOLYLMALEIMIDES F. HOFFMANN-LA ROCHE AG (CH) 2002-09-25 EP disclosed
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US disclosed
WO-2001046178-A2 SUBSTITUIERTE BISINDOLYMALEIMIDE F. HOFFMANN-LA ROCHE AG (CH) 2001-06-28 WO disclosed